Labiotech.eu

News and Trends 29 Mar 2018

Cancer Trial Halted in the UK After Overdosing First Patient

Redx Pharma has temporarily interrupted recruitment in a Phase I/IIa cancer trial following “significant adverse events” of its drug on the first patient treated. The first time Redx Pharma’s cancer drug RXC004 has been tested in a patient has resulted in adverse side effects. According to Redx, the dose tested resulted in a higher exposure […]

March 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 29 Mar 2018

What Are the Best Funding Strategies for Biotech Startups?

Funding a biotech startup is no easy task and can influence the long-term success of a company. Here are some of the do’s and don’ts of successful biotech fundraising. Learning from failures can be valuable in almost any pursuit, and biotech funding strategies are no exception. For example, when a startup is in the initial stages of […]

March 29, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 28 Mar 2018

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is collaborating with Parkinson’s UK and The Cure Parkinson’s Trust (CPT), two UK charities, to repurpose at least three existing drugs and identify two novel drug targets […]

March 28, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 27 Mar 2018

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

Angle, a UK-based biotech, is developing a non-invasive liquid biopsy that could be better than current diagnostic methods at predicting ovarian cancer. Angle, a company specializing in liquid biopsies, has shown that its Pelvic Mass Triage (PMT) liquid biopsy test can differentiate between benign and cancerous pelvic masses and ovarian cysts in 95% of cases […]

March 27, 2018 - 2 minutesmins - By Alexander Burik

tigenix alofisel takeda stem cell therapy crohns disease

News and Trends 27 Mar 2018

Stem Cell Therapy for Crohn’s Disease Approved in Europe

Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem cell therapy to treat complex perianal fistulas — one of the most disabling complications of Crohn’s disease. The cell therapy represents an alternative to multiple surgeries […]

March 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 26 Mar 2018

Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II

GeNeuro has released Phase IIb data showing that its antibody can reduce brain damage in patients with multiple sclerosis by going after an unusual target: a virus that has been in our genome since ancient times. Paris-based biotech GeNeuro has reported that a treatment it is developing in partnership with Servier has potential to treat […]

March 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Allecra Therapeutics Urinary Tract Infections

News and Trends 26 Mar 2018

New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results

Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German biotech, has obtained positive Phase II trial results for its lead antibiotic candidate for treating urinary tract infections. The drug, AAU101, was given to patients intravenously with cefepemine, another antibiotic […]

March 26, 2018 - 1 minutemin - By Alexander Burik

Best in Biotech 26 Mar 2018

The 10 Biotech Venture Capital Firms in Europe to Watch in 2018

Who’s funding the biotech industry in Europe? I’ve gathered a list of some of the most active European biotech venture capital firms that will be setting the pace of the industry this year. Biotech can do great things, from curing deadly diseases to helping make the plastics industry more sustainable. But there is a common […]

March 26, 2018 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Mar 2018

Biotech VC Goes After Disrupting Animal Health and Nutrition

The French biotech VC Seventure, known for its investments in microbiome health, has launched a €24M fund focused on companies developing animal health and nutrition applications. A new venture capital fund called AVF has been launched today to support animal health and nutrition companies. With €24M at its first closing, the fund created by Seventure Partners in partnership […]

March 23, 2018 - 2 minutesmins - By Alexander Burik

imgonline com ua CompressToSize C9Ojq1qDlJ8Cl

News and Trends 23 Mar 2018

Researchers Give Sight to the Blind With Stem Cell Patch

UK researchers have successfully restored vision in two blind patients by transplanting a stem cell patch into their eyes. Scientists at University College London and Moorfields Eye Hospital, London, have used a stem cell patch to successfully restore vision in two patients with age-related macular degeneration (AMD) in a Phase I trial. Following the stem […]

March 23, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Mar 2018

French Biotech Signs a Deal to Fight Antibiotic Resistance

Deinove is licensing a portfolio of antibiotics for multi-drug resistant bacteria from Redx Pharma. Deinove, based in Montpellier, France, has signed an agreement to use synthetic molecules developed by UK biotech Redx to treat lethal anitbiotic-resistant infections. Redx’s molecules are a new class of antibiotics targeting an enzyme involved in bacterial DNA replication in Gram-negative bacteria. Deinove plans to […]

March 22, 2018 - 1 minutemin - By Alexander Burik

News and Trends 21 Mar 2018

A Personalized Genetic Test for Breast Cancer Arrives in Europe

Agendia will launch a next-generation sequencing test in the EU to determine the chances of metastasis in breast cancer patients. Agendia, a US-Dutch biotech specializing in personalized medicine and molecular diagnostics, has obtained CE marking for the MammaPrint BluePrint Kit, a diagnostic device for breast cancer that uses next-generation sequencing technology. The kit can help clinicians identify […]

March 21, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer Trial Halted in the UK After Overdosing First Patient

What Are the Best Funding Strategies for Biotech Startups?

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

Stem Cell Therapy for Crohn’s Disease Approved in Europe

Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II

New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results

The 10 Biotech Venture Capital Firms in Europe to Watch in 2018

Biotech VC Goes After Disrupting Animal Health and Nutrition

Researchers Give Sight to the Blind With Stem Cell Patch

French Biotech Signs a Deal to Fight Antibiotic Resistance

A Personalized Genetic Test for Breast Cancer Arrives in Europe

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!